FRNDS Cannula vs Plethysmography Belts for Respiratory Monitoring
(FRNDS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a new device, the FRNDS cannula (flow-regulated nasal oxygen delivery system), can measure breathing as accurately as current methods like plethysmography belts. The FRNDS cannula not only measures inhaled air but also delivers oxygen, which could benefit those needing supplemental oxygen. The goal is to ensure this new device performs as well as existing tools for tracking breathing. Healthy adults without a history of nasal surgeries or major health issues related to the lungs, heart, or muscles are ideal candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to the development of innovative medical technology.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the study involves healthy adults without chronic conditions, it's likely that participants are not on regular medications for such conditions.
What prior data suggests that the FRNDS cannula is safe for respiratory monitoring?
Research shows that the FRNDS cannula is a new tool designed to measure air intake and output while also providing air. It has been tested in a lab using a model and has achieved about 80% accuracy in measuring breathing. However, it has not yet been tested on people.
Similar devices, such as high-flow nasal cannulas, have been used safely in hospitals. Studies have shown they work well and are safe for delivering oxygen to patients in need. This suggests that the FRNDS cannula might also be safe for people, but further testing is necessary.
The current study aims to determine if the FRNDS cannula performs as well as other methods and if it is safe for healthy individuals. Since it is being tested on healthy participants, it is likely considered low-risk. However, it remains a new device and has not been approved for general use.12345Why are researchers excited about this trial?
Researchers are excited about the FRNDS device because it offers a new way to monitor and support breathing. Unlike traditional methods like plethysmography belts, which only measure respiratory volumes, the FRNDS device can both measure tidal volume in real time and deliver variable amounts of air to the patient. This dual function could provide more accurate monitoring and better respiratory support, potentially leading to improved patient outcomes.
What evidence suggests that the FRNDS cannula is effective for respiratory monitoring?
This trial will compare the Flow-regulated nasal oxygen delivery system (FRNDS) with Plethysmography belts for respiratory monitoring. Studies have shown that high-flow nasal cannulae, which are special tubes delivering oxygen, can lower the breathing rate and improve oxygen levels. They ease breathing and increase lung air volume. The new FRNDS device builds on this concept, designed to measure breathing while providing additional air. In lab tests, the FRNDS device accurately measured breathing 80% of the time compared to standard methods. This suggests that FRNDS might be a good option for measuring breathing in real-life situations, especially for those needing extra oxygen.16789
Are You a Good Fit for This Trial?
This trial is for healthy individuals to test a new nasal oxygen delivery system called FRNDS. It's designed for people who need their breathing measured while getting air or oxygen. Participants should not have respiratory failure or conditions that could interfere with the device's testing.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Measurement
Participants undergo continuous measurement of tidal volumes using FRNDS device and RIP belts
Data Analysis
Data collected from the FRNDS device and RIP belts is analyzed for accuracy and comparison
Follow-up
Participants are monitored for any adverse effects and results are shared
What Are the Treatments Tested in This Trial?
Interventions
- Flow-regulated nasal oxygen delivery system (FRNDS)
Trial Overview
The study tests if the FRNDS cannula can measure breath volumes as well as standard methods, like RIP belts, in healthy subjects. The goal is to see if it can accurately deliver and adjust airflow while measuring breathing without needing mouth-based spirometry.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
FRNDS is a novel cannula device that can both measure tidal volume (VT) in real time while simultaneously delivering air to the patient. Study subjects with undergo continuous measurement of a patient's VT while simultaneously delivering variable volumes of air to the patient and comparing these results with VTs captured with conventional technology (RIP belts)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Virginia Polytechnic Institute and State University
Lead Sponsor
Carilion Clinic
Collaborator
Published Research Related to This Trial
Citations
Clinical Comparison of Flow Regulated Nasal Oxygen ...
SUMMARY: This is a quantitative, non-inferiority study using healthy participants to compare tidal volumes at rest measured by both a standard RIP belt and ...
2.
trial.medpath.com
trial.medpath.com/clinical-trial/f8ed6ed96a092d0a/nct06713213-clinical-comparison-nasal-oxygen-deliveryClinical Comparison of Flow Regulated Nasal Oxygen ...
SUMMARY: This is a quantitative, non-inferiority study using healthy participants to compare tidal volumes at rest measured by both a standard RIP belt and ...
Accuracy of noncontact surface imaging for tidal volume ...
Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end ...
Oxygen delivery through high-flow nasal cannulae ...
This study suggests that HFNCs reduce respiratory rate and improve oxygenation by increasing both EELV and tidal volume and are most beneficial in patients ...
Physiological comparison of noninvasive ventilation and high ...
In patients at high-risk of extubation failure, prophylactic NIV significantly decreased inspiratory efforts with increased tidal volumes compared to HFNO.
6.
ctv.veeva.com
ctv.veeva.com/study/clinical-comparison-of-flow-regulated-nasal-oxygen-delivery-system-frnds-cannula-and-plethysmograpClinical Comparison of Flow Regulated Nasal Oxygen ...
FRNDS is a novel cannula device that can both measure tidal volume (VT) in real time while simultaneously delivering air to the patient.
High-flow nasal oxygen therapy and noninvasive ...
HFNC can deliver high FiO2 compared to other oxygen delivery systems, through a higher flow rate, up to 70 L/min, which in most cases exceeds the patient peak ...
Efficacy and safety of high-flow nasal cannula therapy in ...
HFNC is an effective and safe alternative in elderly patients with ARF not due to COVID-19, refractory to treatment with conventional oxygen therapy and/or ...
Accuracy of noncontact surface imaging for tidal volume ...
Time-of-flight camera enables continuous and non-contact respiratory monitoring under high-flow nasal canula, and enables to detect tidal volume ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.